Results 121 to 130 of about 4,676,099 (307)

Nonlinear dynamics of CAR-T cell therapy [PDF]

arXiv
Chimeric antigen receptor T-cell (CAR-T) therapy is considered a promising cancer treatment. The dynamic response to this therapy can be broadly divided into a short-term phase, ranging from weeks to months, and a long-term phase, ranging from months to years.
arxiv  

Late allograft dysfunction secondary to BKV ureteritis in renal transplantation – Can modification of immunosuppression and ureteral stenting be the savior: Case report

Indian Journal of Transplantation, 2016
Ureteritis due to human polyoma BK virus (BKV) is an emerging complication among renal transplant recipients mimicking rejection. The current mainstay of intervention is to reduce the immunosuppressive maintenance therapy.
Hira Lal, Anupma Kaul, Dharmendra Bhaduaria, R K Sharma, Manas R Patel, Tushant Kumar, A Srivastava   +6 more
doaj   +1 more source

Posttransplant lymphoproliferative disorders in neuronal xenotransplanted macaques [PDF]

, 2016
Posttransplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of lymphoid proliferations that occur in the setting of depressed T-cell function due to immunosuppressive therapy used following solid organ transplantation, hematopoietic ...
Aron Badin, R., Cavicchioli, L., Cozzi, E., Crossan, C., Danesi, A., Ferraresso, S., Hantraye, P., Kaliyaperumal, S., Knight, H., Scobie, L., Trez, D., Vadori, M., Westmoreland, S.   +12 more
core   +1 more source

Tolerance induced without immunosuppression in a t-lymphocyte suicide-gene therapy cardiac allograft model in mice [PDF]

, 2000
E. Braunberger, Nathalie Raynal-Raschilas, Véronique Thomas‐Vaslin, Patrick Bruneval, Jean‐Noël Fabiani, A Carpentier, Denis Glotz, David Klatzmann   +7 more
openalex   +1 more source

Understanding Immune Dynamics in Liver Transplant Through Mathematical Modeling [PDF]

arXiv
Liver transplant can be a life-saving procedure for patients with end-stage liver disease. With the introduction of modern immunosuppressive therapies, short-term survival has significantly improved. However, long-term survival has not substantially improved in decades.
arxiv  

Emergence of SARS-CoV-2 with Dual-Drug Resistant Mutations During a Long-Term Infection in a Kidney Transplant Recipient [Corrigendum]

Infection and Drug Resistance
Tanino Y, Nishioka K, Yamamoto C, et al. Infect Drug Resist. 2024:17:531–541. Our authors have advised that there are two sentences that needed revision in the abstract section of the published paper.
Tanino Y, Nishioka K, Yamamoto C, Watanabe Y, Daidoji T, Kawamoto M, Uda S, Kirito S, Nakagawa Y, Kasamatsu Y, Kawahara Y, Sakai Y, Nobori S, Inaba T, Ota B, Fujita N, Hoshino A, Nukui Y, Nakaya T   +18 more
doaj  

Tumor-associated CD19$^+$ macrophages induce immunosuppressive microenvironment in hepatocellular carcinoma [PDF]

arXiv
Tumor-associated macrophages are a key component that contributes to the immunosuppressive microenvironment in human cancers. However, therapeutic targeting of macrophages has been a challenge in clinic due to the limited understanding of their heterogeneous subpopulations and distinct functions. Here, we identify a unique and clinically relevant CD19$^
arxiv  

T-Cell Suicide Gene Therapy for Organ Transplantation: Induction of Long-Lasting Tolerance to Allogeneic Heart without Generalized Immunosuppression [PDF]

, 2000
Éric Braunberger, José L. Cohen, Olivier Boyer, Béatrice Pegaz-Fiornet, Nathalie Raynal-Raschilas, Patrick Bruneval, Véronique Thomas‐Vaslin, Bertrand Bellier, Alain Carpentier, Denis Glotz, David Klatzmann   +10 more
openalex   +1 more source

Tailoring immunosuppressive therapy [PDF]

Nephrology Dialysis Transplantation, 2002
Dirk Kuypers, Y. C. Vanrenterghem
openaire   +3 more sources

Cardiovascular morbidity and mortality after kidney transplantation [PDF]

, 2014
Kidney transplantation is the optimal treatment for patients with end stage renal disease (ESRD) who would otherwise require dialysis. Patients with ESRD are at dramatically increased cardiovascular (CV) risk compared to the general population.
Jardine, Alan G., Mark, Patrick B., Stoumpos, Sokratis   +2 more
core   +1 more source